ODENSOMAB
Brand Name: ODENSOMAB
Composition (Active Ingredient): Denosumab Injection 60 mg/mL (r-DNA Origin)
Marketed/Manufactured By: LUPIN
Product Description
Medical Info
ODENSOMAB is a prescription-strength Denosumab injection (r-DNA Origin) manufactured by LUPIN. Formulated at a concentration of 60 mg/mL, this sterile solution contains no preservatives and is packaged as a single-use pre-filled syringe. Developed for subcutaneous use only, this specialized biologic medication plays a crucial role in targeted bone-health therapies. To ensure patient safety, the injection must be administered in strict accordance with clinical protocols. For complete instructions regarding dosage schedules, proper disposal, and full safety warnings, healthcare professionals and patients must consult the detailed prescribing information provided in the enclosed package insert.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
